+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Antacids Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904677
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Positioned at the crossroads of consumer health and clinical demand, the antacids market is evolving rapidly in response to shifting consumer preferences, regulatory frameworks, and global supply chain complexities. Strategic leaders recognize that successfully navigating this sector requires both operational acumen and forward-looking market intelligence.

Market Snapshot: Antacids Market Size and Growth Drivers

The antacids market grew from USD 8.88 billion in 2025 to USD 9.31 billion in 2026. It is projected to expand at a CAGR of 4.82% and reach USD 12.35 billion by 2032. This steady growth is propelled by increased consumer focus on self-care, dual demand from clinical and retail channels, and the ongoing need for supply chain resilience.

Scope and Segmentation of the Antacids Market

  • Formulation Types: Tablets, gels, liquids, powders, effervescents, and ready-to-use formats
  • Active Ingredient Profiles: Aluminum hydroxide, magnesium hydroxide, calcium carbonate, sodium bicarbonate, and combination products
  • Distribution Channels: Hospital pharmacy procurement, retail pharmacy, supermarkets, and digital commerce channels
  • Procurement Preferences: Institutional buyers, wholesalers, and direct-to-consumer segments
  • Geographic Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific
  • Operational Themes: Formulation innovation, supply chain continuity, sustainability, and regulatory pathways

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Consumer demand is migrating toward convenience-led product formats and digital purchase channels, reshaping go-to-market strategies.
  • Innovation in formulations, such as effervescent tablets and on-the-go gels, responds to a mix of clinical expectations and consumer preferences.
  • Ingredient sourcing and modular manufacturing are increasingly critical in safeguarding supply continuity and supporting rapid SKU adaptation.
  • Regulatory requirements and evolving labeling practices require proactive engagement across clinical, commercial, and compliance teams.
  • Procurement patterns differ by channel, necessitating tailored packaging, SKU breadth, and trade partner engagement strategies.
  • Sustainability and traceability are emerging as differentiators, with institutional and retail buyers placing increased importance on documented ingredient stewardship.

Tariff Impact: Navigating Policy-Induced Cost Pressures

With new tariff measures introduced in 2025, the antacids supply network faces enhanced scrutiny around sourcing strategies and cost management. Manufacturers are responding by increasing domestic and alternative sourcing, renegotiating supplier contracts, and adopting tariff pass-through pricing approaches. These adjustments are shaping risk management strategies and reinforcing the need for supply chain transparency and scenario planning.

Methodology & Data Sources

This report uses a rigorous methodology combining primary stakeholder interviews, value chain mapping, and secondary literature review. Data inputs from procurement leaders, formulators, and regulatory experts were cross-validated with documented best practices and scenario analysis. Strict ethical and confidentiality standards ensured reliable and actionable findings.

Why This Antacids Market Report Matters

  • Enables executives to anticipate shifts in product, channel, and sourcing strategies through actionable intelligence.
  • Provides a blueprint for aligning operational decisions with evolving market realities, regulatory mandates, and regional competitiveness.
  • Supports strategic planning around supply continuity, formulation adaptation, and differentiated commercialization approaches.

Conclusion

The antacids market demands an integrated approach that combines supply resilience, regulatory diligence, and adaptive commercial strategies. Leaders equipped with clear market insights and operational agility will be better positioned to meet changing expectations in this complex and evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Antacids Market, by Active Ingredient
8.1. Aluminum Hydroxide
8.2. Calcium Carbonate
8.3. Magnesium Hydroxide
8.4. Sodium Bicarbonate
8.5. Combination Formulations
9. Antacids Market, by Form
9.1. Tablet
9.1.1. Chewable Tablet
9.1.2. Effervescent Tablet
9.1.3. Film Coated Tablet
9.2. Liquid
9.2.1. Oral Suspension
9.2.2. Syrup
9.3. Powder
9.3.1. Sachet Powder
9.3.2. Granules
10. Antacids Market, by Flavor
10.1. Mint
10.2. Citrus
10.3. Berry
10.4. Unflavored
11. Antacids Market, by Therapeutic Application
11.1. Heartburn
11.2. Acid Reflux And GERD Symptom Relief
11.3. Indigestion And Dyspepsia
11.4. Bloating
12. Antacids Market, by Distribution Channel
12.1. Hospital Pharmacy
12.2. Online Retail
12.3. Retail Pharmacy
12.4. Supermarket/Hypermarket
13. Antacids Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Antacids Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Antacids Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Antacids Market
17. China Antacids Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Adcock Ingram Limited Co.
18.7. Advance Pharmaceutical Inc.
18.8. Akums Drugs and Pharmaceuticals Ltd.
18.9. Alkem Laboratories Ltd.
18.10. AstraZeneca UK Ltd
18.11. Bayer AG
18.12. Boehringer Ingelheim International GmbH,
18.13. CIPLA LIMITED
18.14. Dr. Reddy’s Laboratories Ltd
18.15. GlaxoSmithKline plc
18.16. Haleon plc
18.17. Johnson & Johnson Services, Inc.
18.18. Novartis AG
18.19. Perrigo Company plc
18.20. Pfizer Inc
18.21. Procter & Gamble Co.
18.22. Reckitt Benckiser Group plc
18.23. Safetec of America, Inc.
18.24. SPI Pharma by ABFI
18.25. Sun Pharmaceutical Industries Ltd
18.26. Takeda Pharmaceutical Company Limited
18.27. WellSpring Pharmaceutical Corporation
18.28. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL ANTACIDS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANTACIDS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANTACIDS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANTACIDS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANTACIDS MARKET SIZE, BY FLAVOR, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANTACIDS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ANTACIDS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ANTACIDS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ANTACIDS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANTACIDS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANTACIDS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANTACIDS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANTACIDS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANTACIDS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANTACIDS MARKET SIZE, BY CALCIUM CARBONATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANTACIDS MARKET SIZE, BY CALCIUM CARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTACIDS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTACIDS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTACIDS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANTACIDS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTACIDS MARKET SIZE, BY SODIUM BICARBONATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTACIDS MARKET SIZE, BY SODIUM BICARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTACIDS MARKET SIZE, BY COMBINATION FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTACIDS MARKET SIZE, BY COMBINATION FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTACIDS MARKET SIZE, BY COMBINATION FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTACIDS MARKET SIZE, BY CHEWABLE TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANTACIDS MARKET SIZE, BY CHEWABLE TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANTACIDS MARKET SIZE, BY CHEWABLE TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANTACIDS MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANTACIDS MARKET SIZE, BY EFFERVESCENT TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANTACIDS MARKET SIZE, BY EFFERVESCENT TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANTACIDS MARKET SIZE, BY FILM COATED TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTACIDS MARKET SIZE, BY FILM COATED TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANTACIDS MARKET SIZE, BY FILM COATED TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANTACIDS MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANTACIDS MARKET SIZE, BY ORAL SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANTACIDS MARKET SIZE, BY ORAL SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTACIDS MARKET SIZE, BY SYRUP, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANTACIDS MARKET SIZE, BY SYRUP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTACIDS MARKET SIZE, BY SYRUP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANTACIDS MARKET SIZE, BY SACHET POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANTACIDS MARKET SIZE, BY SACHET POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANTACIDS MARKET SIZE, BY SACHET POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANTACIDS MARKET SIZE, BY GRANULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANTACIDS MARKET SIZE, BY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANTACIDS MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANTACIDS MARKET SIZE, BY MINT, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANTACIDS MARKET SIZE, BY MINT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANTACIDS MARKET SIZE, BY MINT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANTACIDS MARKET SIZE, BY CITRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANTACIDS MARKET SIZE, BY CITRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANTACIDS MARKET SIZE, BY CITRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANTACIDS MARKET SIZE, BY BERRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANTACIDS MARKET SIZE, BY BERRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANTACIDS MARKET SIZE, BY BERRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANTACIDS MARKET SIZE, BY UNFLAVORED, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANTACIDS MARKET SIZE, BY UNFLAVORED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANTACIDS MARKET SIZE, BY UNFLAVORED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANTACIDS MARKET SIZE, BY HEARTBURN, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANTACIDS MARKET SIZE, BY HEARTBURN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANTACIDS MARKET SIZE, BY HEARTBURN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANTACIDS MARKET SIZE, BY ACID REFLUX AND GERD SYMPTOM RELIEF, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANTACIDS MARKET SIZE, BY ACID REFLUX AND GERD SYMPTOM RELIEF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANTACIDS MARKET SIZE, BY ACID REFLUX AND GERD SYMPTOM RELIEF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANTACIDS MARKET SIZE, BY INDIGESTION AND DYSPEPSIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANTACIDS MARKET SIZE, BY INDIGESTION AND DYSPEPSIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANTACIDS MARKET SIZE, BY INDIGESTION AND DYSPEPSIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANTACIDS MARKET SIZE, BY BLOATING, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANTACIDS MARKET SIZE, BY BLOATING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANTACIDS MARKET SIZE, BY BLOATING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ANTACIDS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ANTACIDS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ANTACIDS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ANTACIDS MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ANTACIDS MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ANTACIDS MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS ANTACIDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. EUROPE ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. EUROPE ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 130. EUROPE ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 131. EUROPE ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 132. EUROPE ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 133. EUROPE ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 135. EUROPE ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. EUROPE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. AFRICA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 148. AFRICA ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 149. AFRICA ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 150. AFRICA ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 151. AFRICA ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 152. AFRICA ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 153. AFRICA ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL ANTACIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. ASEAN ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. ASEAN ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 167. ASEAN ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 168. ASEAN ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 169. ASEAN ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 170. ASEAN ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 171. ASEAN ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 172. ASEAN ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. ASEAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174. GCC ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GCC ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 176. GCC ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 177. GCC ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 178. GCC ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 179. GCC ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 180. GCC ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 181. GCC ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. GCC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 192. BRICS ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. BRICS ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 194. BRICS ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 195. BRICS ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 196. BRICS ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 197. BRICS ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 198. BRICS ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 199. BRICS ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. BRICS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 201. G7 ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. G7 ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 203. G7 ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 204. G7 ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 205. G7 ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 206. G7 ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 207. G7 ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 208. G7 ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. G7 ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. NATO ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. NATO ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 212. NATO ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 213. NATO ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 214. NATO ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 215. NATO ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 216. NATO ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 217. NATO ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. NATO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES ANTACIDS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. CHINA ANTACIDS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. CHINA ANTACIDS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 231. CHINA ANTACIDS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 232. CHINA ANTACIDS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 233. CHINA ANTACIDS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 234. CHINA ANTACIDS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 235. CHINA ANTACIDS MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 236. CHINA ANTACIDS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Antacids market report include:
  • Abbott Laboratories
  • Adcock Ingram Limited Co.
  • Advance Pharmaceutical Inc.
  • Akums Drugs and Pharmaceuticals Ltd.
  • Alkem Laboratories Ltd.
  • AstraZeneca UK Ltd
  • Bayer AG
  • Boehringer Ingelheim International GmbH,
  • CIPLA LIMITED
  • Dr. Reddy’s Laboratories Ltd
  • GlaxoSmithKline plc
  • Haleon plc
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc
  • Procter & Gamble Co.
  • Reckitt Benckiser Group plc
  • Safetec of America, Inc.
  • SPI Pharma by ABFI
  • Sun Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Company Limited
  • WellSpring Pharmaceutical Corporation
  • Zydus Lifesciences Limited

Table Information